Archive for June 9th, 2011

XOMA lacks efficacy. DSCO mixed shelf + ACAD MRNA PARD

Jun 09, 2011 No Comments by

DISCOVERY LABORATORIES, INC. (Nasdaq: DSCO) filed a mixed shelf to the value of $200m yesterday. XOMA Ltd. (Nasdaq:XOMA), released six-month top line results from a Phase 2a clinical trial of XOMA 052 in 74 patients with Type 2 diabetes after hours yesterday. The data showed that there was no significant differences between the XOMA 052 […]

Daily News Read more